Status:
TERMINATED
Ketorolac Use in Pediatric Patients Undergoing Tonsillectomy
Lead Sponsor:
Albany Medical College
Conditions:
Analgesic Adverse Reaction
Eligibility:
All Genders
2-18 years
Phase:
PHASE4
Brief Summary
This prospective, randomized, double blinded study is designed to compare the bleeding rates of ketorolac vs. placebo when used for post tonsillectomy pain control in pediatric patients ages 2-18.
Detailed Description
Tonsillectomy/adenoidectomy is an elective operation, mainly in the pediatric population. This procedure is performed by Dr. Jason Mouzakes and the otolaryngology residents under his supervision. The ...
Eligibility Criteria
Inclusion
- ASA physical status I to III, age of 2 years to 18 years old (inclusive) scheduled for elective tonsillectomy with or without adenoidectomy.
Exclusion
- Exclusion criteria are: allergy to any nonsteroidal anti-inflammatory medications, bleeding disorders, history of gastrointestinal bleeding, renal impairment, severe asthma, cardiac/hepatic disease, use of anticoagulation, recent NSAID use (within last 72 hours) or any other medical problem that in the opinion of investigator would interfere with study participation.
Key Trial Info
Start Date :
November 21 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2022
Estimated Enrollment :
214 Patients enrolled
Trial Details
Trial ID
NCT03453541
Start Date
November 21 2017
End Date
November 1 2022
Last Update
October 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Albany Medical Center
Albany, New York, United States, 12208